These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17716180)

  • 1. Patents and nanomedicine.
    Bawa R
    Nanomedicine (Lond); 2007 Jun; 2(3):351-74. PubMed ID: 17716180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protecting new ideas and inventions in nanomedicine with patents.
    Bawa R; Bawa SR; Maebius SB; Flynn T; Wei C
    Nanomedicine; 2005 Jun; 1(2):150-8. PubMed ID: 17292072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of recent US Supreme Court IP ruling for nanomedicine patents.
    Kim KY
    Nanomedicine (Lond); 2008 Apr; 3(2):141-3. PubMed ID: 18373420
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of effective patents on future innovations in nanomedicine.
    Bosetti R; Vereeck L
    Pharm Pat Anal; 2012 Mar; 1(1):37-43. PubMed ID: 24236712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in basic and clinical nanomedicine.
    Morrow KJ; Bawa R; Wei C
    Med Clin North Am; 2007 Sep; 91(5):805-43. PubMed ID: 17826104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patenting nanotechnology.
    Lemley MA
    Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will the nanomedicine "patent land grab" thwart commercialization?
    Bawa R
    Nanomedicine; 2005 Dec; 1(4):346-50. PubMed ID: 17292108
    [No Abstract]   [Full Text] [Related]  

  • 8. Changing emphasis in test for patent infringement.
    Moran P
    Med Device Technol; 2005 Mar; 16(2):28. PubMed ID: 15828498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirical analysis of major stem cell patent cases: the role of universities.
    Mills AE; Tereskerz PM
    Nat Biotechnol; 2010 Apr; 28(4):325-8. PubMed ID: 20379173
    [No Abstract]   [Full Text] [Related]  

  • 10. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patenting of genome research results.
    Stolzenburg F; Weinzierl G; Jaenichen HR
    Pharmacogenomics; 2003 Sep; 4(5):633-42. PubMed ID: 12943469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are the Brookhill-Wilk patents impediments to market growth in cybersurgery?
    McLean TR; Torrance AW
    Int J Med Robot; 2008 Mar; 4(1):3-9. PubMed ID: 18275034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulating nanomedicine - can the FDA handle it?
    Bawa R
    Curr Drug Deliv; 2011 May; 8(3):227-34. PubMed ID: 21291376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic-cell-based technology landscape: Insights from patents and citation networks.
    Kong X; Hu Y; Cai Z; Yang F; Zhang Q
    Hum Vaccin Immunother; 2015; 11(3):682-8. PubMed ID: 25714961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter partes reexamination: a potentially useful approach to challenging invalid biotechnology patents.
    Derzko NM; Behringer JW
    Nat Biotechnol; 2003 Jul; 21(7):823-5. PubMed ID: 12833101
    [No Abstract]   [Full Text] [Related]  

  • 16. Time waits for no man: deciding when to file a patent application in Europe.
    White NL
    Nat Biotechnol; 2007 Jun; 25(6):639-41. PubMed ID: 17557096
    [No Abstract]   [Full Text] [Related]  

  • 17. Past versus present: the importance of tense in patent application examples.
    Potter JE; Talukder G
    Nat Biotechnol; 2003 Nov; 21(11):1397-8. PubMed ID: 14595370
    [No Abstract]   [Full Text] [Related]  

  • 18. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 2. Pharma's challenges and their commitment to innovation.
    Abou-Gharbia M; Childers WE
    J Med Chem; 2014 Jul; 57(13):5525-53. PubMed ID: 24428137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Publish and perish: what constitutes a bar under the patent laws.
    Teitelbaum R; Cohen MS
    Nat Biotechnol; 2004 Nov; 22(11):1449-51. PubMed ID: 15529168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patents in Nanobiotechnology: A Cross Jurisdictional Approach.
    Manchikanti P; Uppala S; Bonta RK
    Recent Pat Biotechnol; 2017; 11(1):52-70. PubMed ID: 27881055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.